Stocks · Health care · Biological Products, (No Diagnostic Substances)

Gilead Sciences

GILD Clue Score57
United States Fiscal year ends December CIK 0000882095 Results filed 29 Oct 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Daniel Patrick O'Day
30 Oct 2026
Chairman & CEO
Sold after exercise
15,881
$175.25
$2.78M

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 15,881
History held since 29 Sep 2006